Tavira Therapeutics
Gaston Geenslaan 1
3001 Leuven
BE
Tavira Therapeutics
Foundation date
9th June 2024
Sector
#Biotechnology - TherapeuticsSubsector
Transforming gene therapy with our advanced AAV delivery platform.
Unlock the future of gene therapy with Tavira’s targeted AAV gene delivery platform.
Enhancing the targeting capacity of recombinant AAVs for gene therapy through tailor made capsid conjugation
Upcoming events
All events-
1012 '24
Next-Generation Synthetic Biology
Event by: VIB -
0312 '24
BioFIT 2024
Event by: Eurasanté -
0204 '25
The Franco-Belgian Agrifood Summit
Event by: CCI France - Belgique
Latest news
More news-
Bio Base Europe Pilot Plant successfully commissions a 75,000 L fermenter, demonstrating Vivici’s Vivitein™ BLG technology in industrial-scale precision fermentation
13 hours ago
Read more
-
argenx Advances Clinical Development of Efgartigimod SC in Idiopathic Inflammatory Myopathies
1 day ago
Read more
-
ExeVir Announces Michael Garrett as New Chief Executive Officer
Tuesday November 19th 2024
Read more
Jobs
More jobs-
-
-
20/11/24
Antwerp
Postdoc position in the Laboratory for Gut-Immune-Brain Axis Research
Permanent
VIB
More info?
Contact us
Ellen Telleir
Communication Coordinator